Virtuvax provides strategic advice, technology and expertise for the development of vaccines. This includes the design and management of an R&D program until a strategy for market access. In addition, we provide off-the-shelf technology, for influenza vaccines as well as technology for mucosal delivery of vaccines. Altogether, Virtuvax enables the swift transition of your product to a marketed vaccine. Let's make technology work.
THE COMPANY
Founded in 2016, Virtuvax B.V. aims to make vaccine technology work! Virtuvax is headed by Dr. Ernst Soethout and provides consultancy for:
-
Design and management of vaccine R&D programs
-
Interim management
-
Business development and market access strategies for vaccines
WE HELP
Virtuvax serves various parties with advice and expertise:
-
Vaccine companies
-
Biotech companies, universities and knowledge institutes
-
Biopharmaceutical industry
-
Public health agencies
